Medical Article: Extending Tamoxifen Reduces Recurrence Risk, Saves Lives

Posted By on December 17th, 2012 at 8:03 am | 0 comments.

The results of the ATLAS (Adjuvant Tamoxifen: Longer Against Shorter) study indicates that 10 years of Tamoxifen is even better than the standard 5 years of treatment in reducing the chance of recurrence and saving lives. The study showed that mortality and recurrence risk was reduced among the segment of 7,000 women participating in the study who continued taking Tamoxifen for an additional 5 years. As always, women should discuss individualized treatment options with their doctors.

Leave a Reply